Sponsored Links
-->

Friday, January 19, 2018

The development of immunoconjugates for targeted cancer therapy ...
src: media.springernature.com

Immunoconjugates are antibodies conjugated (joined) to a second molecule, usually a toxin, radioisotope or label.

These conjugates are used in immunotherapy and to develop monoclonal antibody therapy as a targeted form of chemotherapy when they are often known as antibody-drug conjugates.

When the conjugates include a radioisotope see radioimmunotherapy. When the conjugates include a toxin see immunotoxin.


Video Immunoconjugate



References


Maps Immunoconjugate



Further reading

  • Technology Insight: cytotoxic drug immunoconjugates for cancer therapy. 2007 looks useful from the abstract.
  • Targeted Therapy of Cancer: New Prospects for Antibodies and Immunoconjugates. 2006 full article, 18 pages.
  • Arming antibodies: prospects and challenges for immunoconjugates. 2005 10 pages.


Source of article : Wikipedia